S100A9 and pneumonia: Besides these pro-inflammatory properties of S100A9, there are also anti-microbial effects associated with S100A9 expression, as in pneumonia-induced sepsis, where S100A9 reduces bacterial growth [115]; whether this effect is mediated by EMMPRIN is similarly still unknown.